期刊文献+

氟伏沙明在小鼠体内抗抑郁作用的时辰药理学及其机制研究 被引量:3

Study on Chronopharmacology and Its Mechanism of Antidepressant Effect of Fluvoxamine in Mice
原文传递
导出
摘要 目的:研究氟伏沙明在小鼠体内抗抑郁作用的时辰药理学及其可能机制。方法:以生理盐水为对照组,考察相邻2天的9:00、13:00、17:00、21:00、1:00、5:00共6个时间点注射氟伏沙明(30mg.kg-1)对小鼠在水中5min内的不动累积时间的影响,和同日内明、暗期(9:00、21:00)注射氟伏沙明对小鼠在暗箱中10min自发性活动(运动距离、运动时间、静止时间)的影响;另外还检测正常小鼠同日内明、暗期(9:00、21:00)脑组织中5羟色胺(5-HT)转运体(SERT)mRNA表达、5-HT再摄取浓度、sigma-1受体的变化。结果:与对照组比较,氟伏沙明能显著缩短小鼠的不动累积时间(P<0.01),其中21:00组不动累积时间最低,但不影响小鼠自发性活动;与明期(9:00)组比较,正常小鼠暗期(21:00)组脑组织中SERTmRNA表达和5-HT再摄取浓度及sigma-1受体的表达均明显升高(P<0.05)。结论:氟伏沙明在小鼠体内的抑郁作用具有昼夜节律性,该作用可能与中脑SERTmRNA的表达、sigma-1受体表达的昼夜节律变化相关。 OBJECTIVE: To study chronopharmacology and its mechanism of antidepressant effect of fluvoxamine in mice. METHODS: With normal saline as control, the influence of fluvoxamine (30 mg.kg-1) at 9:00, 13:00, 17:00, 21:00, 1:00 and 5 : 00 of consecutive 2 days on the immobility time of mice in water was investigated, and the influence of fluvoxamine at 9: 00 and 21:00 on the same day on 10 min spontaneous activity of mice in dark box (movement distance, movement time and rest time) was also studied. Serotonin transporter (SERT) mRNA expression and 5-hydroxytryptamine (5-HT) uptake concentration and sig- ma-1 receptor in cerebral tissue of normal mice were detected at 9:00 and 21:00 on the same day. RESULTS: Compared with con- trol group, fluvoxamine could shorten the immobility time of mice significantly (P〈0.01). The immobility time of mice was the lowest at 21 : 00, which didn' t influence spontaneous activity of mice. Compared with light phase (9: 00) group, SERT mRNA ex- pression, 5-HT uptake concentration and sigma-1 receptor expression in cerebral tissue of normal mice increased significantly at dark phase (21: 00) group (P〈0.05). CONCLUSION: Anti-depressive effect of fluvoxamine exhibits a significant circadian rhythm, the mechanism of which might lie in the time-dependent changes of SERT mRNA expression and sigma receptor expression in the midbrain.
出处 《中国药房》 CAS CSCD 2012年第13期1177-1179,共3页 China Pharmacy
关键词 氟伏沙明 时辰药理学 强迫性游泳 抗抑郁作用 小鼠 Fluvoxamine Chronopharmacology Forced swimming test Antidepressant effect Mice
  • 相关文献

参考文献13

  • 1Bruhn C.Chronopharmacology:exact timing of drug dose improves the treatment outcome[J].Dtsch Med Wochenschr,2009,134(20):p20.
  • 2Lemmer B.Chronopharmacology--importance of the biological clock in drug treatment[J].Med Monatsschr Pharm,2009,32(11):419.
  • 3Jakovljevic′M.Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress:a wishfull thinking or an innovative strategy for superior management of depression?[J].Psychiatr Danub,2011,23(1):2.
  • 4Ohdo S,Koyanagi S,Matsunaga N.Chronopharmacology[J].Nihon Yakurigaku Zasshi,2011,137(3):115.
  • 5Vinkers CH,Groenink L,Pattij T,et al.5-HT(1A)receptor sensitivity in5-HT(1B)receptor KO mice is unaffected by chronic fluvoxamine treatment[J].Eur J Pharmacol,2011,667(13):250.
  • 6姜红,韩迎.抗抑郁药物新进展[J].中国药房,2004,15(5):308-310. 被引量:34
  • 7许月芳,姜玲敏.2006~2008年我院抗抑郁药应用分析[J].中国医院用药评价与分析,2010,10(3):237-239. 被引量:4
  • 8Hindmarch I,Hashimoto K.Cognition and depression:the effects of fluvoxamine,a sigma-1receptor agonist,reconsidered[J].Hum Psychopharmacol,2010,25(3):193.
  • 9Ago Y,Yano K,Hiramatsu N,et al.Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both5-HT reuptake inhibition and sigma(1)receptor activation[J].Psychopharmacology(Berl),2011,217(3):377.
  • 10Ushijima K,Sakaguchi H,Sato Y,et al.Chronopharmacological study of antidepressants in forced swimming test of mice[J].J Pharmacol Exp Ther,2005,315(2):764.

二级参考文献21

  • 1Speiser Z, Fine T, Litinetsky L, et al . Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline[ J]. J Neural Transm, 2008, 115 (1) :107.
  • 2Benazzi F. Fluoxetine for the treatment of SSRI discontinuation syndrome [ J]. Int J Neuropsychopharmacol, 2008, 11(5) :725.
  • 3Yoshimura R, Umene - Nakano W, Suzuki A, et al. Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients [ J]. Hum Psychopharmacol,2009, 24 (6) :489.
  • 4Birkett DP. Behavioral therapy, sertraline, or both in childhood anxiety [ J ]. N Engl J Med, 2009, 360 (23): 2476.
  • 5Santangelo A, Testai M, Barbagallo P, et al. Use of specific serotonin reuptake inhibitors (SSRIs) ( Sertraline or Citalopram) in the treatment of depression reduces the cardiovascular risk in the elderly: evidence from a Sicilian population > 80 years recovered in the assisted sanitary residences (RSA) [ J ]. Arch Gerontol Geriatr, 2009,48 (3) :350.
  • 6Rademacher S, Dietz R, Haverkamp W. QT prolongation and syncope with methadone, doxepin, and a beta- blocker[J]. Ann Pharmacother,2005, 39(10):1 762.
  • 7Ilina NA. Experience of the use of velaxin (venlafaxine) in anxious depression[ J ]. Neurosci Behav Physiol,2009, 39(3) :305.
  • 8张少丽,石少波.抑郁症治疗的研究进展[J].精神医学杂志,2008,21(2):156-160. 被引量:59
  • 9方英立,张保同.帕罗西汀临床应用及评价[J].中国医院药学杂志,1999,19(3):163-164. 被引量:7
  • 10施慎逊,李华芳,王义方,王立伟,陆峥,张海音,顾牛范,舒良,周沫,陈远光,赵靖平.噻奈普汀治疗抑郁症的临床疗效研究[J].中华精神科杂志,2000,33(3):171-174. 被引量:20

共引文献36

同被引文献16

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部